Predictions
Molecular Templates Inc.
Start price
Target price
Perf. (%)
€5.50
04.10.21
04.10.21
-
04.10.22
04.10.22
-1.36%
17.10.21
17.10.21
Risky Investment
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€2.60
04.10.21
04.10.21
-
04.10.22
04.10.22
-4.62%
16.10.21
16.10.21
Capable Management
Could be very worthwhile Investment >20% year
Few uniques
Valneva SE
Start price
Target price
Perf. (%)
€12.95
03.10.21
03.10.21
€20.00
03.10.22
03.10.22
15.83%
16.10.21
16.10.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€51.56
03.10.21
03.10.21
-
03.10.22
03.10.22
1.55%
17.10.21
17.10.21
Could be very worthwhile Investment >20% year
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€4.12
03.10.21
03.10.21
-
03.10.22
03.10.22
3.86%
17.10.21
17.10.21
Risky Investment
Geratherm Medical AG
Start price
Target price
Perf. (%)
€9.46
03.10.21
03.10.21
-
03.10.22
03.10.22
-10.78%
04.06.22
04.06.22
Could be very worthwhile Investment >20% year
Omeros Corp.
Start price
Target price
Perf. (%)
€7.20
02.10.21
02.10.21
-
02.10.22
02.10.22
-53.29%
03.10.22
03.10.22
Probably not worthwhile Investment
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€2.46
30.09.21
30.09.21
-
30.09.22
30.09.22
0.00%
02.10.21
02.10.21
Risky Investment
Nicox S.A.
Start price
Target price
Perf. (%)
€3.19
29.09.21
29.09.21
€3.80
29.09.22
29.09.22
-46.37%
30.09.22
30.09.22
Could be worthwhile Investment >10% per year
Deciphera Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
29.09.21
29.09.21
€40.00
31.12.24
31.12.24
-67.96%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Flexion Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.40
29.09.21
29.09.21
€10.00
31.12.24
31.12.24
43.52%
11.10.21
11.10.21
Could be very worthwhile Investment >20% year
Editas Medicine Inc
Start price
Target price
Perf. (%)
€46.67
29.09.21
29.09.21
€35.00
31.10.22
31.10.22
-16.73%
29.09.21
29.09.21
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€19.92
28.09.21
28.09.21
-
28.09.22
28.09.22
-6.85%
02.10.21
02.10.21
Could be worthwhile Investment >10% per year
Insmed Inc.
Start price
Target price
Perf. (%)
€23.60
27.09.21
27.09.21
€40.00
31.12.23
31.12.23
-25.00%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Genfit S.A.
Start price
Target price
Perf. (%)
€3.36
26.09.21
26.09.21
-
26.09.22
26.09.22
14.15%
27.09.22
27.09.22
Could be worthwhile Investment >10% per year
PhaseBio Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€2.62
25.09.21
25.09.21
€5.00
31.12.23
31.12.23
-97.42%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.55
20.09.21
20.09.21
€4.00
20.09.22
20.09.22
-13.87%
30.09.21
30.09.21
Good culture
Probably not worthwhile Investment
Below average Management
Little innovation
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.79
20.09.21
20.09.21
-
20.09.25
20.09.25
-26.16%
03.04.23
03.04.23
Could be worthwhile Investment >10% per year
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.50
20.09.21
20.09.21
-
20.09.22
20.09.22
29.09%
21.09.21
21.09.21
Could be worthwhile Investment >10% per year
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€2.84
20.09.21
20.09.21
€4.00
20.09.22
20.09.22
-13.38%
02.10.21
02.10.21
Capable Management
Could be very worthwhile Investment >20% year
Few uniques
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.20
20.09.21
20.09.21
€4.00
20.09.22
20.09.22
-22.69%
22.10.21
22.10.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Innovative
Verastem Inc.
Start price
Target price
Perf. (%)
€34.22
20.09.21
20.09.21
€60.00
31.12.23
31.12.23
-88.71%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
MacroGenics Inc.
Start price
Target price
Perf. (%)
€16.79
19.09.21
19.09.21
-
19.09.22
19.09.22
-79.51%
20.09.22
20.09.22
Probably not worthwhile Investment